Agoracom: Small Cap Investment - Zenith Epigenetics - Re: Reports of Exempt Distribution

Zenithepigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free

Reply New Message

Back To Forum List View

Reports of Exempt Distribution

1

Feb 04, 2023 09:01AM

Re: Reports of Exempt Distribution

1

Feb 06, 2023 11:59AM

Re: Reports of Exempt Distribution

1

Feb 06, 2023 12:53PM

Re: Reports of Exempt Distribution

2

Feb 09, 2023 07:23AM

Re: Reports of Exempt Distribution

5

Feb 09, 2023 08:01AM

Re: Reports of Exempt Distribution

3

Feb 09, 2023 08:30AM

Re: Reports of Exempt Distribution

3

Feb 09, 2023 08:54AM

Re: Reports of Exempt Distribution

2

Feb 09, 2023 10:08AM

Re: Reports of Exempt Distribution

3

Feb 21, 2023 12:58PM

Re: Reports of Exempt Distribution

2

Feb 22, 2023 09:43AM

Re: Reports of Exempt Distribution

1

Feb 23, 2023 02:56PM

Re: Reports of Exempt Distribution

Feb 23, 2023 05:05PM

Re: Reports of Exempt Distribution

1

Feb 24, 2023 10:39AM

Re: Reports of Exempt Distribution

2

Nextblockbuster

Feb 24, 2023 11:27AM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Reports of Exempt Distribution

in response to

Re: Reports of Exempt Distribution

by

posted on Feb 24, 2023 12:05PM

Log in to use the IP Check tool ^[?]

We have no details on the debentures so it difficult to say how they will turn out. Not sure if debentures offer any liquidity for ZHCLF.

Koo

Loading...

Loading...

Reply New Message

Back To Forum List View

Share

Share

Share

Please to post a reply